Dr. Moss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
33 North Drive
Building 33
Bethesda, MD 20892- Is this information wrong?
Education & Training
- New York University School of MedicineClass of 1961
Publications & Presentations
PubMed
- 19 citationsSPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.Ruikang Liu, Jorge D. Mendez-Rios, Chen Peng, Wei Xiao, Andrea S. Weisberg, Linda S. Wyatt, Bernard Moss> ;Plos Pathogens. 2019 May 30
- 54 citationsHIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challengeAndrew T. Jones, Xiaoying Shen, Korey L. Walter, Celia C. LaBranche, Linda S. Wyatt, Georgia D. Tomaras, David C. Montefiori, Bernard Moss, Dan H. Barouch, John D. Cle...> ;Nature Communications. 2019 Feb 18
- 9 citationsNovel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.Lynette S. Chea, Linda S. Wyatt, Sailaja Gangadhara, Bernard Moss, Rama Rao Amara> ;Journal of Virology. 2019 Feb 19
- Join now to see all
Journal Articles
- RNA Polymerase Mutations Selected During Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replac...Bernard Moss, MD, mBio
Press Mentions
- Moving TargetSeptember 16th, 2022
- GeoVax Announces Issuance of Hepatitis B Vaccine PatentJuly 7th, 2021
- GeoVax Receives Notice of Allowance for Hepatitis B Vaccine PatentApril 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: